Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07011862 · ClinicalTrials.gov registry record · NA

COBRA: Cancer, Older Adults, Balance and Resistance Activities

A NA study of Cancer and Metastatic Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
NA
Development phase
38
Enrollment target
6
Study locations

NCT07011862 is a NA study of Cancer and Metastatic Cancer that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 38 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 6 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07011862, a NA study of Cancer and Metastatic Cancer, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
NA
Development phase
38 participants
Enrollment target
6
Study locations

Study Summary

The purpose of this study is to find out whether an 8-week digital health promotion program called COBRA is a safe and practical (feasible) option for older adults with cancer/OAC.

Interventions

  • BEHAVIORAL Cancer, Older adults, Balance and Resistance Activities

Study Locations (6)

New York

  • Memorial Sloan Kettering Suffolk-Commack (Consent Only) - Commack
  • Memorial Sloan Kettering Westchester (Consent only) - Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites) - New York
  • Memorial Sloan Kettering Nassau (Consent Only) - Uniondale

New Jersey

  • Memorial Sloan Kettering Monmouth (Consent only) - Middletown
  • Memorial Sloan Kettering Bergen (Consent Only) - Montvale

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2025-05-30
Est. Completion 2027-05-30
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT07011862

The ClinicalTrials.gov registry entry for NCT07011862 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Cancer, Older adults, Balance and Resistance Activities is the first listed.

NCT07011862 reports 6 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.

Frequently Asked Questions

What is clinical trial NCT07011862 about?

NCT07011862 is a clinical study titled "COBRA: Cancer, Older Adults, Balance and Resistance Activities". The purpose of this study is to find out whether an 8-week digital health promotion program called COBRA is a safe and practical (feasible) option for older adults with cancer/OAC.

What is the current status of trial NCT07011862?

This trial is currently recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2025-05-30. Estimated completion is 2027-05-30.

What conditions does trial NCT07011862 study?

This clinical trial studies the following conditions: Cancer, Metastatic Cancer, Primary Cancer.

What interventions are being tested in trial NCT07011862?

The interventions under investigation include: Cancer, Older adults, Balance and Resistance Activities (BEHAVIORAL).

Who is sponsoring clinical trial NCT07011862?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07011862 being conducted?

This trial has 6 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.